|
THAP10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.214360E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.815400E-03 |
| Normal-vs-Stage2 |
2.039000E-01 |
| Normal-vs-Stage3 |
2.820000E-01 |
| Normal-vs-Stage4 |
1.343890E-03 |
| Stage1-vs-Stage2 |
9.199400E-01 |
| Stage1-vs-Stage3 |
5.309000E-01 |
| Stage1-vs-Stage4 |
2.382200E-01 |
| Stage2-vs-Stage3 |
7.666600E-01 |
| Stage2-vs-Stage4 |
3.656400E-01 |
| Stage3-vs-Stage4 |
2.317000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.884900E-03 |
| Normal-vs-AfricanAmerican |
2.256000E-01 |
| Normal-vs-Asian |
3.817800E-02 |
| Caucasian-vs-AfricanAmerican |
3.542400E-01 |
| Caucasian-vs-Asian |
5.983600E-01 |
| AfricanAmerican-vs-Asian |
3.925000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.128000E-02 |
| Normal-vs-Female |
9.329600E-02 |
| Male-vs-Female |
6.951400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.084020E-02 |
| Normal-vs-Extreme_Weight |
7.880600E-03 |
| Normal-vs-Obese |
3.218000E-01 |
| Normal-vs-Extreme_Obese |
3.003400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.790800E-01 |
| Normal_Weight-vs-Obese |
1.703450E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.398200E-01 |
| Extreme_Weight-vs-Obese |
1.848840E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.581600E-01 |
| Obese-vs-Extreme_Obese |
6.331400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.708000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.438760E-01 |
| Normal-vs-Age(61-80Yrs) |
8.565000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.343200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.933400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.156200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.687000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.105400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.121570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.099000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.241800E-01 |
| Normal-VS-Type2 PRCC |
4.3803999999481E-06 |
| Normal-VS-KIRP CIMP |
2.618200E-03 |
| Normal-VS-Unclassified PRCC |
7.615500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.32280000000263E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.056900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.061200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.792600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.802100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.090200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.41029999999265E-05 |
| Normal-vs-N1 |
3.933400E-01 |
| Normal-vs-N2 |
2.643700E-03 |
| N0-vs-N1 |
8.160400E-02 |
| N0-vs-N2 |
4.296000E-01 |
| N1-vs-N2 |
1.921050E-01 |
|
|
